Sanofi’s Sarclisa gets approved as a first-line option for some patients newly diagnosed with multiple myeloma

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Conversations about improving prenatal care must include transgender and gender diverse birthing people

I dreamed of having children from a young age — so much so that I assumed I had to be a cisgender woman. Society had

August 29, 2024

Long Q4 Lifts Organigram Revenue

Organigram Reports Fiscal 2023 Results¹ Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D. Organigram continues to

December 19, 2023

MIND Institute receives $4.7 million to study child-focused autism intervention in community agencies

UC Davis MIND Institute researchers have received a $4.7 million, five-year grant from the National Institutes of Mental Health to study a child-focused autism intervention

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.